Significant efficacy in a phase 2 study of NKTR-102, a novel polymer conjugate of Irinotecan, in patients with pre-treated metastatic breast cancer (MBC)

Authors
Publication date
1 December 2010
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Open Repository and Bibliography - Liège

    redirect
    oaioai:orbi.ulg.ac.be:2268/175362
    Last time updated on 03/08/2016